Filippo Acconcia

Filippo Acconcia

Oct 14, 2017

Group 6 Copy 99
0
    Please wait...

    About This Project

    70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can Data Management Tools Improve Research Efficiency and Reproducibility?

    Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

    How Do Fats Help Us Treat Brain Cancer?

    Malignant Brain Tumors will kill over 13,000 cancer patients this year in the United States alone; brain tumors...

    Can we use our immune cells to fight lung disease?

    Acute respiratory distress syndrome (ARDS) is a common deadly illness often seen in the intensive care unit...

    Campaign Ended